Skip to content
Screener

Sight Sciences, Inc. SGHT Q1 2026 earnings

Reported May 6, 2026 · After market close

Revenue$19.7MBeat by $1.2M
EPS-$0.16Beat by $0.03
Revenue estimate$18.5M
EPS estimate-$0.19

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$23.6M
EPS estimate-$0.13

Financials

Q1 2026

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K—
Free cash flow-$7.1M+38.9%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$203.6M+65.3%
Enterprise value$159.53M+191%
P/S2.6×+1.0×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Segments

By segment

See full
Surgical Glaucoma$18.3M+7.2%
Dry Eye$1.4M+244%

FAQ

When did Sight Sciences, Inc. report Q1 2026 earnings?
Sight Sciences, Inc. (SGHT) reported Q1 2026 earnings on May 6, 2026 after market close.
What were Sight Sciences, Inc.'s Q1 2026 revenue and EPS?
Sight Sciences, Inc. reported revenue of $19.7M and eps of $-0.16 for Q1 2026.
Did Sight Sciences, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $18.5M by $1.2M. EPS beat the consensus estimate of $-0.19 by $0.03.
How did Sight Sciences, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 12.5% from $17.5M a year earlier and eps grew 42.9% from $-0.28.
Where can I find Sight Sciences, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-208959) and the 10-Q periodic report (0001193125-26-209116) directly on SEC EDGAR. The filing index links above go to sec.gov.